| Revista Brasileira de Cirurgia Cardiovascular | |
| Prescribility of generic microemulsion Cyclosporine A in heart transplant patients | |
| Ricardo Manrique2  Hélio M. Magalhães2  Jarbas Dinkhuysen2  Edileide Correia2  Hui Tsu Lin-wang2  Marcos Vasconcellos2  Eliete Carvalho2  Juan A. C. Mejia1  João D De Souza Neto1  | |
| [1] ,Dante Pazzanese de Cardiology Institute | |
| 关键词: Cyclosporine; Cyclosporine; Cyclosporine; Immunossupressives; Heart transplantation; Ciclosporina; Ciclosporina; Ciclosporina; Imunossupressores; Transplante de coração; | |
| DOI : 10.1590/S0102-76382003000200008 | |
| 来源: SciELO | |
PDF
|
|
【 摘 要 】
OBJECT: This paper aims to define the prescribility (therapeutic efficacy and bio-safety) of generic microemulsion Cyclosporin (Sigmasporin Microral®). METHOD: Casuistic: Twenty heart transplantation patients, 13 males and 7 females, with a mean age of 49.6 years, began immunosuppression treatment with generic microemulsion cyclosporin (Sigmasporin Microral®). They underwent clinical and laboratory evaluation during a minimum of three months. Procedures included clinic evaluation with electro and echocardiogram, endomyocardial biopsy, routine biochemical and hematological tests. RESULTS: The mean follow-up was 10 months with a maximum of 16 months. A total of 151 endomyocardial biopsies were evaluated: 31.7% were degree 0, 43.7% 1a and 23.1% 1b. We had only one case of acute clinical rejection confirmed by biopsy as IIIa, and one patient with mediastinitis, both of whom had a good evolution. The mean cyclosporin blood level was 303 Ng/mL. All other parameters also showed a good evolution. CONCLUSION: Generic microemulsion cyclosporin (Sigmasporin Microral®) shows therapeutic efficacy and an excellent bio-safety profile. Its Prescribility is confirmed.
【 授权许可】
CC BY
All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License
【 预 览 】
| Files | Size | Format | View |
|---|---|---|---|
| RO202005130098297ZK.pdf | 154KB |
PDF